Marimed (MRMD) Non-Current Assets (2013 - 2026)
Marimed's (MRMD) quarterly Non-Current Assets came in at $140.4 million in Q1 2026, down 6.4% year-on-year from $150.0 million in Q1 2025, and down 2.01% on a QoQ basis from $143.3 million in Q4 2025.
Marimed (MRMD) Non-Current Assets (2013 - 2026) Analysis & Trends
Marimed (MRMD) has 14 years of Non-Current Assets data on file, last reported at $140.4 million in Q1 2026.
- On a quarterly basis, Non-Current Assets fell 6.4% year-over-year to $140.4 million in Q1 2026; TTM through Mar 2026 was $370.8 million, a 39.7% decrease from a year earlier, with the FY2025 full-year figure at $143.3 million, down 6.65% from the prior year.
- Non-Current Assets for Q1 2026 stood at $140.4 million, down from $143.3 million in the prior quarter.
- Over the last five years, Non-Current Assets for MRMD reached as high as $156.0 million in Q3 2024 and fell as low as -$60.1 million in Q3 2025.
- Historically, Non-Current Assets has averaged $121.8 million across 5 years, with a median of $140.4 million in 2026.
- Across the five-year window, Non-Current Assets jumped 62.13% in 2022 and plunged 138.52% in 2025, its largest moves.
- Year by year, Non-Current Assets stood at $108.1 million in 2022, then surged by 33.9% to $144.7 million in 2023, then climbed by 6.07% to $153.5 million in 2024, then declined by 6.65% to $143.3 million in 2025, then slipped by 2.01% to $140.4 million in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $140.4 million in Q1 2026, $143.3 million in Q4 2025, and -$60.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 36.78 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 26.33 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 8.68 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 79.20 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 3.84 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.70 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 25.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.47 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 9.64 Bn |
| 10 | Marimed | 23.85 Mn | 14.02 Mn | 15.28 Mn | 140.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 140.40 Mn |
| Dec 31, 2025 | 143.28 Mn |
| Sep 30, 2025 | -60.09 Mn |
| Jun 30, 2025 | 147.24 Mn |
| Mar 31, 2025 | 150.00 Mn |
| Dec 31, 2024 | 153.48 Mn |
| Sep 30, 2024 | 156.00 Mn |
| Jun 30, 2024 | 155.48 Mn |
| Mar 31, 2024 | 146.44 Mn |
| Dec 31, 2023 | 144.69 Mn |
| Sep 30, 2023 | 140.03 Mn |
| Jun 30, 2023 | 131.45 Mn |
| Mar 31, 2023 | 125.02 Mn |
| Dec 31, 2022 | 108.06 Mn |
| Sep 30, 2022 | 103.82 Mn |
| Jun 30, 2022 | 102.33 Mn |
| Mar 31, 2022 | 82.67 Mn |
| Dec 31, 2021 | 78.59 Mn |
| Sep 30, 2021 | 68.45 Mn |
| Jun 30, 2021 | 63.11 Mn |